Secondary osteoporosis therapies in rheumatoid arthritis patients

摘要

Method secondary osteoporosis therapy, in patients with rheumatoid arthritis, comprising administering the drug methotrexate individually selected doses of 10-15 mg 1 time per week, non-steroidal anti-inflammatory drugs, D3 calcium, characterized in that additionally intravenously administered drug infusion Aklasta 1 times a year when triply adjunctive therapy with alfacalcidol 1 CIM night for three years.